Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

1:17UpperMakefieldTownshipPoliceDepartmentreleasedthisphotoofKatieSeley,a32-year-oldmotherofthreewho CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy




hotspot

author：focus    Page View：9281
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： UK homeowners get some respite as inflation falls by more than anticipated to a 15
Next article： Jerome Adams on the need for new antivirals for Covid